157,102 Shares in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Acquired by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) during the 3rd quarter, Holdings Channel.com reports. The fund bought 157,102 shares of the company’s stock, valued at approximately $817,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. boosted its position in Aveanna Healthcare by 1.8% during the first quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock valued at $6,402,000 after purchasing an additional 44,970 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in shares of Aveanna Healthcare by 155.8% in the 2nd quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock valued at $438,000 after buying an additional 96,600 shares in the last quarter. Bank of New York Mellon Corp grew its position in shares of Aveanna Healthcare by 6.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock worth $413,000 after buying an additional 9,243 shares during the last quarter. Acadian Asset Management LLC raised its stake in shares of Aveanna Healthcare by 176.6% during the 2nd quarter. Acadian Asset Management LLC now owns 81,275 shares of the company’s stock worth $222,000 after acquiring an additional 51,890 shares in the last quarter. Finally, Creative Planning lifted its position in Aveanna Healthcare by 21.3% during the third quarter. Creative Planning now owns 48,502 shares of the company’s stock valued at $252,000 after acquiring an additional 8,502 shares during the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Aveanna Healthcare Price Performance

Shares of AVAH opened at $5.58 on Friday. The firm has a market capitalization of $1.08 billion, a PE ratio of -16.41 and a beta of 2.13. The company’s fifty day moving average price is $5.22 and its 200-day moving average price is $4.25. Aveanna Healthcare Holdings Inc. has a 1-year low of $2.00 and a 1-year high of $6.19.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.02 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.03. The firm had revenue of $509.02 million during the quarter, compared to analyst estimates of $495.80 million. During the same period in the prior year, the company posted ($0.05) earnings per share. As a group, research analysts anticipate that Aveanna Healthcare Holdings Inc. will post -0.09 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on AVAH shares. UBS Group lifted their price target on shares of Aveanna Healthcare from $1.70 to $2.80 and gave the stock a “sell” rating in a report on Friday, August 9th. Royal Bank of Canada boosted their target price on Aveanna Healthcare from $3.00 to $5.00 and gave the stock a “sector perform” rating in a research note on Friday, August 9th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on Aveanna Healthcare from $3.00 to $5.00 and gave the stock a “buy” rating in a report on Friday, August 9th.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.